Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPP4 Inhibitor vs SGLT2 Inhibitor on Ischemic Burden in T2DM with CAD
NCT03178591Phase 4Completed
- Sponsor
- Chiang Mai University
- Start
- Oct 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin, dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Chiang Mai University. Started Oct 2014; status: completed.
02
Drugs
vildagliptindapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03178591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03178591.